Sign inJoin waitlistJoin the waitlist

Back to University of Kansas School of Medicine Clinical Neurophysiology

Mamatha Pasnoor

Clinical Neurophysiology Fellowship · University of Kansas School of Medicine

Credentials: · ·

History

Clinical Neurophysiology
University of Kansas School of Medicine
2026–Present
Neurology
University of Kansas School of Medicine
2001–2005
Michigan State University Grand Rapids Research Center
1996–1997
Osmania Medical College
1992–1996

Research

The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy
Journal of Diabetes and its Complications · 2012 · 231 citations
Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review
Neurology · 2017 · 181 citations
Treatment of Myasthenia Gravis
Review · Neurologic Clinics · 2018 · 176 citations

Mazen Dimachkie
54 papers
Richard Barohn
47 papers
AM
April Mcvey
12 papers
Omar Jawdat
11 papers · 5 as a fellow
Gil Wolfe
10 papers
James Howard
10 papers
Patricia Kluding
10 papers
JK
John Kissel
8 papers
Constantine Farmakidis
7 papers
Jeffrey Statland
7 papers
Michael Benatar
6 papers
TM
Tahseen Mozaffar
6 papers

Grants

General Clinical Research Center
National Center for Research Resources · M01
Project lead · $41K · University of Kansas Medical Center
2008–2010

Clinical trials

Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy
Principal investigator · Withdrawn · Phase 2
Mamatha Pasnoor, MD
2015–2018
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
Site PI · Recruiting
Takeda
2025–2027
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Site PI · Recruiting · Phase 3
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
2024–2030